Wanpen Vongpatanasin
University of Texas Southwestern Medical Center · Wanpen.Vongpatanasin@UTSouthwestern.edu · UT Southwestern
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
13
all conditions, ClinicalTrials.gov
NIH grants tied to them
9
NIH RePORTER
Trial papers
24
PubMed author-name match
Trials
Studies that name Wanpen Vongpatanasin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05331144 · Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)Rong Zhang · active not recruiting · Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline · principal investigator
- N/ANCT05147909 · Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral AdiposityUniversity of Texas Southwestern Medical Center · recruiting · Physical Inactivity, Phosphate Overload, Visceral Obesity · principal investigator
- N/ANCT03667781 · Therapeutic Drug Monitoring of Cardiac MedicationsUniversity of Texas Southwestern Medical Center · terminated · Hypertension, Coronary Artery Disease · principal investigator
- Ph2NCT03354143 · Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)University of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- N/ANCT02664519 · Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney DiseaseUniversity of Texas Southwestern Medical Center · terminated · Chronic Kidney Disease · principal investigator
- N/ANCT02665117 · Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrateUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- Ph4NCT02653560 · Value of Liquid Potassium Magnesium Citrate in Controlling HypertensionUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- Ph4NCT02102243 · Neural Mechanism of Aldosterone-induced Insulin ResistanceWanpen Vongpatanasin · withdrawn · Hypertension · principal investigator
- Ph2NCT01996449 · The Role of Aldosterone on Augmented Exercise Pressor Reflex in HypertensionUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- Ph2NCT01682837 · Value of Liquid Potassium Magnesium Citrate in Controlling HypertensionUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- Ph4NCT01502787 · Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive PatientsUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- Ph4NCT01501929 · Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive PatientsUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
- Ph4NCT00353652 · Effects of Thiazide Diuretics on Sympathetic Nervous System in HypertensionUniversity of Texas Southwestern Medical Center · completed · Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral AdiposityR01HL159994 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2022 to 2026 · $788,935 awarded in 2026Same name and institution; not confirmed by an ID
- Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)R01AG076660 · NIA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2022 to 2025 · $2,316,231 awarded in 2025Grant number is on one of their registry trials
- Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)R33AG068486 · NIA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2021 to 2024 · $1,238,148 awarded in 2024Same name and institution; not confirmed by an ID
- Hypertension, intracranial pulsatility and brain A-beta accumulation in older adultsR01AG057571 · NIA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2017 to 2021 · $743,929 awarded in 2021Grant number is on one of their registry trials
- Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)R61AG068486 · NIA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2020 · $796,575 awarded in 2020Same name and institution; not confirmed by an ID
- Preventing Hypertension and Sympathetic Overactivation by Targeting PhosphateR01HL133179 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2017 to 2020 · $792,454 awarded in 2020Same name and institution; not confirmed by an ID
- The Role of Aldosterone on Augmented Exercise Pressor Reflex in HypertensionR01HL113738 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2013 to 2016 · $550,995 awarded in 2016Same name and institution; not confirmed by an ID
- Neural Mechanism of Thiazide-Induced Insulin ResistanceR01HL078782 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2005 to 2008 · $369,790 awarded in 2008Grant number is on one of their registry trials
- POSTMENOPAUSAL HORMONAL REPLACEMENT THERAPYK23RR016321 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2002 to 2006 · $104,760 awarded in 2006Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:54 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.Circulation · 2001164 citationsRCR 4.6
- Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.J Am Coll Cardiol · 2003118 citationsRCR 3.2
- Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.Hypertension · 201287 citationsRCR 2.9
- Mechanism of cocaine-induced hyperthermia in humans.Ann Intern Med · 200272 citationsRCR 2.5
- Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.J Clin Endocrinol Metab · 200966 citationsRCR 2.0
- Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.Clin J Am Soc Nephrol · 201254 citationsRCR 2.2
- Effects of the intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans.Circulation · 199845 citationsRCR 1.4
- Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans.J Am Coll Cardiol · 200742 citationsRCR 1.4
- Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women.Arterioscler Thromb Vasc Biol · 200434 citationsRCR 0.8
- Mechanism of the blood pressure--raising effect of cocaine in humans.Circulation · 200233 citationsRCR 0.9